Share
Market Research Report

MACULAR DEGENERATION TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By TypeDry Age-related Macular Degeneration and Wet Age-related Macular Degeneration
  • By Stage Of DiseaseEarly-stage AMD · Intermediate AMD · Late-stage AMD
  • By Route Of AdministrationIntravenous Route and Intravitreal Route
  • By Sales ChannelAmbulatory Surgical Centres · Hospitals · and Other Sales Channels
  • By GeographyNorth America · Europe · Asia-Pacific · Latin America · and Middle East & Africa
  • Published In18 Mar 2026
  • Report CodeCMI5149
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Type
      • Market Snapshot, By Stage of Disease
      • Market Snapshot, By Route of Administration
      • Market Snapshot, By Sales Channel
      • Market Snapshot, By Geography
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Increasing burden of retinal disorders worldwide
      • Lack of awareness regarding macular degeneration
      • Increasing demand for safe and effective treatment
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product launch/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
  4. Macular Degeneration Treatment Market, By Type, 2026-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021-2033
      • Segment Trends
    • Dry Age-related Macular Degeneration
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
    • Wet Age-related Macular Degeneration
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
  5. Macular Degeneration Treatment Market, By Stage of Disease, 2026-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021-2033
      • Segment Trends
    • Early-stage AMD
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
    • Intermediate AMD
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
    • Late-stage AMD
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
  6. Macular Degeneration Treatment Market, By Route of Administration, 2026-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021-2033
      • Segment Trends
    • Intravenous Route
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
    • Intravitreal Route
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
  7. Macular Degeneration Treatment Market, By Sales Channel, 2026-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021-2033
      • Segment Trends
    • Ambulatory Surgical Centres
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
    • Other Sales Channels
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
  8. Macular Degeneration Treatment Market, By Geography, 2026-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021-2033
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026-2033,(USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Stage of Diseases, 2026-2033,(USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033,(USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2026-2033,(USD Bn)
      • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026-2033,(USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Stage of Diseases, 2026-2033,(USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033,(USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2026-2033,(USD Bn)
      • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026-2033,(USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Stage of Diseases, 2026-2033,(USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033,(USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2026-2033,(USD Bn)
      • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026-2033,(USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Stage of Diseases, 2026-2033,(USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033,(USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2026-2033,(USD Bn)
      • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Middle East and Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026-2033,(USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Stage of Diseases, 2026-2033,(USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033,(USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2026-2033,(USD Bn)
      • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
        • South Africa
        • North Africa
        • Central Africa
  9. Competitive Landscape

    • Bayer AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • REGENXBIO Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Aerie Pharmaceutical Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Panoptica
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Hoffmann-La Roche Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Regeneron Pharmaceutical Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bausch Health Companies Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Analyst Views
  10. Section

    • Research Methodology
    • About us